Is LPCN or LSTA more undervalued in 2026?

CirclFi compares Lipocine Inc. (LPCN) and Lisata Therapeutics, Inc. (LSTA) using 13 institutional-grade valuation models. LPCN has a Quality of Company score of 5.4/10 while LSTA scores 5.2/10.

Which is a better buy — LPCN or LSTA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do LPCN and LSTA valuations compare?

LPCN at $2.26 and LSTA at $3.30 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

LPCN vs LSTA Valuation Comparison 2026 — Intrinsic Value Analysis

LPCN

Biotechnology

Lipocine Inc.

Quality

5.4

out of 10

Value Trap

SAFE

Price

$2.26

Last close

Models

9/13

Active

LSTA

Biotechnology

Lisata Therapeutics, Inc.

Quality

5.2

out of 10

Value Trap

SAFE

Price

$3.30

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	LPCN Fair Value	LPCN Upside	LSTA Fair Value	LSTA Upside
Bayesian DCF	Intrinsic	$0.94	-58.5%	$1.67	-49.3%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$4.50	+99.1%	$3.19	-3.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for LPCN vs LSTA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

LPCN vs LSTA — Which Stock Is More Undervalued?

LPCN scores higher with a 5.4/10 quality rating vs LSTA's 5.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Lipocine Inc. (LPCN) and Lisata Therapeutics, Inc. (LSTA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

LPCN currently trades at $2.26 with a QOC of 5.4/10, while LSTA trades at $3.30 with a QOC of 5.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).